Aventis Pharma Inc. v. Apotex Inc. et al., (2005) 278 F.T.R. 1 (FC)

This document cites

• Bull (David) Laboratories (Canada) Inc. v. Pharmacia Inc. et al., (1994) 176 N.R. 48 (FCA)
• Biovail Pharmaceuticals Inc. et al. v. Canada (Minister of National Health and Welfare) et al., 2005 FC 9
• Apotex Inc. v. Canada (Minister of National Health and Welfare) et al., (1997) 219 N.R. 151 (FCA)
• Novartis AG et al. v. Apotex Inc. et al., (2002) 298 N.R. 348 (FCA)
• Bristol-Myers Squibb Co. et al. v. Canada (Attorney General) et al., (2005) 334 N.R. 55 (SCC)



See all quotations

• AB Hassle v. Can., (2000) 256 N.R. 172 (FCA)
• Merck & Co. et al. v. Apotex Inc., (1998) 146 F.T.R. 148 (TD)
• Whirlpool Corp. et al. v. Camco Inc. et al., (2000) 263 N.R. 88 (SCC)
• Procter & Gamble v. Can., 2004 FCA 393
• Johnson Controls Inc. v. Varta Batteries Ltd., (1984) 53 N.R. 6 (FCA)
• Free World Trust v. Électro Santé Inc. et al., (2000) 263 N.R. 150 (SCC)
• Merck Frosst Canada Inc. et al. v. Canada (Minister of National Health and Welfare) et al., (1998) 227 N.R. 299 (SCC)
• Beloit Canada Ltd. v. Valmet Oy, (1986) 64 N.R. 287 (FCA)
• Visx Inc. v. Nidek Co. et al., (1996) 209 N.R. 342 (FCA)
• Monsanto Co. v. Commissioner of Patents, (1979) 28 N.R. 181 (SCC)
• Killam v. Manuge, (1972) 4 N.S.R.(2d) 884 (SCC)
• Pfizer Can. Inc. v. Novopharm, 2005 FCA 270
• Merck & Co. et al. v. Apotex Inc. et al., 2005 FC 755
• Mayne Pharma (Canada) Inc. v. Aventis Pharma Inc. et al., (2005) 331 N.R. 373 (FCA)
• Burton Parson Chemicals Inc. et al. v. Hewlett-Packard (Canada) Ltd. et al., (1974) 3 N.R. 553 (SCC)
• Allied Signal Inc. v. Du Pont Canada Inc. and Complax Corp., (1995) 184 N.R. 113 (FCA)
• AB Hassle et al. v. Genpharm Inc. et al., (2003) 243 F.T.R. 6 (FC)
• Canamould Extrusions Ltd. et al. v. Driangle Inc., 2004 FCA 63
• AT&T Technologies Inc. v. Mitel Corp., (1989) 28 F.T.R. 241 (TD)
• Merck & Co. et al. v. Apotex Inc., (1995) 180 N.R. 373 (FCA)
• Mobil Oil Corp. et al. v. Hercules Canada Inc., (1995) 188 N.R. 382 (FCA)
• Novartis Pharmaceuticals Canada Inc. et al. v. Abbott Laboratories Ltd. et al., (2000) 258 N.R. 105 (FCA)
• Bayer Inc. et al. v. Canada (Minister of National Health and Welfare) et al., (2000) 258 N.R. 238 (FCA)
• Glaxo Group Ltd. et al. v. Canada (Minister of National Health and Welfare) et al., (1995) 103 F.T.R. 1 (TD)
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., (2001) 266 N.R. 371 (FCA)
• Apotex Inc. and Novopharm Ltd. v. Wellcome Foundation Ltd., (2002) 296 N.R. 130 (SCC)
• AstraZeneca AB et al. v. Apotex Inc. et al., (2005) 335 N.R. 1 (FCA)
• Procter & Gamble Co. v. Beecham Canada Ltd. and Calgon Interamerican Corp., (1982) 40 N.R. 313 (FCA)
• Aventis Pharma Inc. et al. v. Pharmascience Inc. et al., 2005 FC 340
• Airseal Controls Inc. v. M & I Heat Transfer Products Ltd., (1993) 72 F.T.R. 196 (TD)